Evidence map›Paper›PMID 38357946›Full record

ArticleCurrent medicinal chemistry2025

Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO

Yao Su, Lin Chen, Jin Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. [Role and mechanisms of FoxO3a-related signaling pathways in breast cancer cell apoptosis].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yao SuDepartment of Urology Surgery, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu, China.ORCID 0000-0003-1389-7673
Lin ChenDepartment of Urology Surgery, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu, China.ORCID 0000-0002-0109-2651
Jin YangDepartment of Urology Surgery, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu, China.ORCID 0000-0002-0715-3371
Chengdu Medical College · CN

Funding

Chengdu Science and Technology 2020-YF05-00153-SN, 2019-YF05-00162-SNNatural Science Foundation from Department of Science and Technology of Sichuan Province 2022NSFSC1592Sichuan Medical (Youth Innovative) Scientific research projects S19017, S17002, Q18014, Q19022, Q20013
6 · The paper itself

Abstract

BACKGROUND AND

objectivesHesperetin (HSE) is a natural flavonoid derived from the hydrolysis of Hesperidin, which is mainly found in traditional natural Chinese herbs, such as Chenpi and Hovenia caryophyllus. HSE displays anti-inflammatory and antioxidant activities. However, its potential mechanism of action on bladder cancer (BLCA) remains unknown. The aim of this study was to investigate the potential mechanism of action of HSE on BLCA cells.

methodsNetwork pharmacology analysis was used to construct a composite target network, combined with Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis to identify HSE-induced cell death patterns and signaling pathway alterations. Cytotoxicity evaluation was determined by CCK-8 assay. A clone formation assay was performed to assess cell proliferative capacity. Scratch and Transwell assays were performed to evaluate cell migration and invasion ability. Hoechst 33342 staining was visualized to observe morphological features of apoptosis. Apoptosis, cycle distribution, reactive oxygen species (ROS) generation, and mitochondrial membrane potential (MMP) changes were examined by flow cytometry. Western blot analysis was performed to analyze the expression of key proteins associated with cell proliferation, apoptosis, cycle block, PI3K/AKT/FoxO

resultsNetwork pharmacology analysis was performed to identify 155 potential candidate targets of HSE-BLCA, and further topological analysis was performed to obtain 34 hub-gene. Enrichment analysis yielded patterns of death and key pathways, revealing that the anti-BLCA effect of HSE may be related to the positive regulation of PI3K/AKT/FoxO

conclusionThe anticancer effects of HSE in BLCA may be attributed to its coordination of actions, inhibiting cell proliferation, migration, and invasion, inducing apoptosis, G0/G1 phase arrest, generating reactive oxygen species, causing MMP loss, and engaging the caspase protein family. These actions are likely mediated through the PI3K/AKT/FoxO

Indexed as

Antineoplastic AgentsApoptosisCell Cycle CheckpointsHesperidinUrinary Bladder NeoplasmsCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorEndoplasmic Reticulum StressForkhead Box Protein O3HumansMembrane Potential, MitochondrialMitochondriaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAntineoplastic AgentsForkhead Box Protein O3FOXO3 protein, humanhesperetinHesperidinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen Speciesapoptosisbladder cancercycle arrestER stress-mitochondrial pathway.HesperetinPI3K/AKT/FoxO3a

Identifiers

PMID38357946
OpenAlexW4391846495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.